ADC Therapeutics SA
Change company Symbol lookup
Select an option...
ADCT ADC Therapeutics SA
HOV Hovnanian Enterprises Inc
SIRI Sirius XM Holdings Inc
NVEI Nuvei Corp
JNJ Johnson & Johnson
AVGO Broadcom Inc
GILD Gilead Sciences Inc
LLY Eli Lilly and Co
ABBV Abbvie Inc
CIEN Ciena Corp
Go

Health Care : Biotechnology | Small Cap Value
Based in Switzerland
Company profile

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Price
Delayed
$2.95
Day's Change
0.075 (2.61%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.99
Day's Low
2.77
Volume
(Light)

Today's volume of 176,109 shares is on pace to be much lighter than ADCT's 10-day average volume of 526,344 shares.

176,109
  • Prev Close
    2.87
  • Today's Open
    2.87
  • Day's Range
    2.77-2.99
  • Avg Vol (10-day)
    526.3K
  • Last (time)
    12:09p ET 12/08/22
  • Last (size)
    100
  • 52-Wk Range
    2.75 - 22.52
    LowHigh
  • (12/23/21 - 12/07/22)
    7.09%
  • 79.0%
  • Market Cap
    228.7M
  • Shares Outstanding
    77.6M
  • -2.15
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 51.07
  • (% of float 11/15/22)
    16.98

Latest News

November 28, 2022
9:47 am ET
BusinessWire
November 08, 2022
7:00 am ET
BusinessWire
November 07, 2022
7:15 am ET
BusinessWire
November 03, 2022
9:34 am ET
BusinessWire
November 02, 2022
4:05 pm ET
Globe Newswire
4:05 pm ET
BusinessWire
November 01, 2022
7:15 am ET
BusinessWire
October 31, 2022
7:15 am ET
BusinessWire
September 27, 2022
6:18 pm ET
Globe Newswire
September 21, 2022
7:00 pm ET
BusinessWire
September 20, 2022
8:00 am ET
Globe Newswire
September 17, 2022
8:48 pm ET
Newsfile
September 16, 2022
7:15 am ET
BusinessWire
September 15, 2022
2:30 pm ET
Accesswire
September 14, 2022
2:00 pm ET
Accesswire
11:17 am ET
BusinessWire
September 13, 2022
8:19 pm ET
BusinessWire
September 12, 2022
4:15 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.